Cue Biopharma, Inc.

Leadership moves, last update 2 months ago

Pharma biotech · Headquarters Boston, United States

Everything we hold on Cue Biopharma, Inc., newest first. Every line links to the filing or report it came from.

1. 2026-06-03
   Headcount Not Stated Leadership moves

   Cue Biopharma, Inc. 8-K filing (Item 5.02): officer or director change

   Cue Biopharma's stockholders approved a new stock incentive plan, indicating a focus on executive compensation but not disclosing any immediate hiring plans.

   Boston, United States · Official Filing · SEC EDGAR

2. 2026-05-14
   Headcount Not Stated Growing and expanding

   Cue Biopharma, Inc. raised $30M in a private placement

   Cue Biopharma, Inc. reported a $30M private placement to the SEC on 2026-05-14, listing an address in Boston, MA. The filing records the money only; it names no roles and no hiring plan.

   Boston, United States · $30M raised · Official Filing · SEC EDGAR (Form D)

3. 2026-02-12
   Headcount Not Stated Leadership moves

   Cue Biopharma, Inc. 8-K filing (Item 5.02): officer or director change

   Cue Biopharma promotes its Chief Business Officer to a combined financial and business leadership role in Boston, signaling continuity in executive leadership.

   Boston, United States · Official Filing · SEC EDGAR

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker